(Reuters) - Previously untreated patients experienced significant and lasting reductions in signs and symptoms of psoriatic arthritis when given Celgene Corp's experimental oral drug, apremilast, according to data from a late stage clinical trial.

via Reuters: Health News Read More Here..
No comments:
Post a Comment